St. Petersburg, Florida: MediNcrease Health Plans, LLC (MediNcrease), a national provider network and provider advocacy firm, is pleased to announce the addition of Bioventus to its national provider network. MediNcrease clients and payers will benefit from this contractual arrangement with Bioventus. “We are thrilled to welcome Bioventus, a global leader in active orthopaedic healing, to the MediNcrease Provider Network”, said Linda Plaster, Chief Executive Officer of MediNcrease Health Plans. “This exciting relationship affirms continued commitment to our specialty provider network expansion.”

This agreement means nearly 5.5 million individuals represented by MediNcrease clients will now have access to the EXOGEN® Ultrasound Bone Healing System a treatment that stimulates the body’s natural healing process1, helping fractured bones mend. When treating fractures, EXOGEN may be a cost-effective alternative to more invasive options.*

About Bioventus

Bioventus LLC is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.BioventusGlobal.com and follow the company on Twitter @Bioventusglobal

About MediNcrease Health Plans

MediNcrease is a uniquely positioned national provider network and provider advocacy firm servicing the commercial health, workers’ compensation and auto medical markets. Our advanced provider network and negotiation solutions not only help facilitate millions of dollars in expedited payments to providers each year, but also provide medical payers with dramatically improved savings and service over traditional PPO networks. The result is a 100% defensible and transparent solution for both providers and payers.

MediNcrease Media Contact:
Chris Vaughn, Marketing Manager
Phone (855) 369-3923
cvaughn@medincrease.com

Bioventus Media Contact:
Thomas Hill, Director of Corporate Communications
Phone: (919) 474-6715
thomas.hill@bioventusglobal.com

Bioventus and EXOGEN are registered trademarks of Bioventus LLC

*Summary of Indications for Use

The EXOGEN Ultrasound Bone Healing System is indicated for the non-invasive treatment of established non-unions excluding skull and vertebra. In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopaedically managed by closed reduction and cast immobilization. There are no known contraindications for the EXOGEN device. Safety and effectiveness have not been established for individuals lacking skeletal maturity, pregnant or nursing women, patients with cardiac pacemakers, on fractures due to bone cancer, or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel. Full prescribing information can be found in product labeling at www.exogen.com or by calling customer service at 1-800-836-4080. A non-union is considered to be established when the fracture site shows no visibly progressive signs of healing.

      Azuma Y, Ito M, Harada Y, Takagi H, Ohta T, Jingushi S. Low-intensity pulsed ultrasound accelerates rat femoral fracture healing by acting on the various cellular reactions in the fracture callus. J Bone Miner Res. 2001; 16(4):671-680.